Genetically targeted mTORC1 inhibitor reveals transcriptional control by nuclear mTORC1

Yanghao Zhong1,2,3, Ayse Z Sahan1,2,4, Zhengyao Shao1

  • 1Department of Pharmacology, University of California, San Diego, La Jolla, CA, USA.

Insights

Mechanistic target of rapamycin complex 1 (mTORC1) signaling is compartmentalized. A new tool, TerminaTOR, reveals mTORC1

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Mechanistic target of rapamycin complex 1 (mTORC1) is a key nutrient sensor regulating protein translation and cell growth.
  • While traditionally localized to the lysosome, mTORC1 signaling is now known to occur at various subcellular locations, including the nucleus.
  • The specific functions and compartmentalization of mTORC1 signaling at these distinct locations remain largely unknown.

Purpose of the Study:

  • To investigate the subcellular functions of mTORC1.
  • To develop a tool for interrogating spatially distinct mTORC1 signaling pools.
  • To elucidate the roles of nuclear mTORC1 in gene regulation.

Main Methods:

  • Development of TerminaTOR, a genetically encodable, location-specific mTORC1 inhibitor.
  • Targeting TerminaTOR to lysosomes to study canonical mTORC1 functions and induce autophagy.
  • Targeting TerminaTOR to the nucleus to specifically inhibit nuclear mTORC1 activity.

Main Results:

  • Lysosomal targeting of TerminaTOR successfully inhibited lysosomal mTORC1 and induced autophagy.
  • Nuclear targeting of TerminaTOR specifically inhibited nuclear mTORC1.
  • Nuclear mTORC1 was found to play a noncanonical role in regulating the transcription of CCAAT motif-containing genes.

Conclusions:

  • mTORC1 signaling exhibits functional spatial compartmentalization within the cell.
  • TerminaTOR is a valuable tool for dissecting the spatially regulated functions of mTORC1.
  • Nuclear mTORC1 has distinct roles in gene transcription, separate from its lysosomal functions.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...